Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis

BackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.Method...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xinwen Zhang, Jialin Duan, Zhenyu Wen, Hao Xiong, Xiaomin Chen, Yang Liu, Kunyu Liao, Chunlan Huang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/eec690c52bbb4f60b59c45289f1ae5ee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eec690c52bbb4f60b59c45289f1ae5ee
record_format dspace
spelling oai:doaj.org-article:eec690c52bbb4f60b59c45289f1ae5ee2021-11-30T13:03:01ZAre the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis2234-943X10.3389/fonc.2021.766672https://doaj.org/article/eec690c52bbb4f60b59c45289f1ae5ee2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.766672/fullhttps://doaj.org/toc/2234-943XBackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.MethodsRelevant literatures were retrieved from PubMed, Embase and Web of Science databases according to PRISMA guideline. All relevant parameters were extracted and combined for statistical analysis.ResultsNineteen studies incorporating 3818 MM patients were eventually included in this meta-analysis. 13 studies evaluated that elevated NLR was significantly associated with poor survival outcomes (OS: HR=2.04, P<0.001; PFS: HR=1.96, P=0.003). Elevated NLR was revealed to correlate with ISS stage (ISS III VS I-II, OR=2.23, P=0.003). A total of 7 studies have shown that elevated LMR predicts a better prognosis in MM patients (OS: HR=0.57, P<0.001; PFS: HR=0.49, P<0.05), and two other studies demonstrated that increased MLR was related to poor OS/PFS (OS: HR=1.58, P<0.05; PFS: HR=1.60, P<0.05). However, in the other 6 studies including 1560 patients, the prognostic value of PLR had not been confirmed (OS: HR=0.89, P>0.05; PFS: HR=0.87, P>0.05).ConclusionsThe indexes NLR and LMR/MLR derived from WBCC were validated to be useful biomarkers to predict the prognosis in MM patients, but the evidence of PLR was insufficient.Xinwen ZhangXinwen ZhangJialin DuanJialin DuanZhenyu WenHao XiongHao XiongXiaomin ChenXiaomin ChenYang LiuYang LiuKunyu LiaoKunyu LiaoChunlan HuangChunlan HuangFrontiers Media S.A.articlemultiple myeloma (MM)neutrophil-to-lymphocyte ratio (NLR)platelet-to-lymphocyte ratio (PLR)lymphocyte-to-monocyte ratio (LMR)monocyte-to-lymphocyte ratio (MLR)prognosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic multiple myeloma (MM)
neutrophil-to-lymphocyte ratio (NLR)
platelet-to-lymphocyte ratio (PLR)
lymphocyte-to-monocyte ratio (LMR)
monocyte-to-lymphocyte ratio (MLR)
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle multiple myeloma (MM)
neutrophil-to-lymphocyte ratio (NLR)
platelet-to-lymphocyte ratio (PLR)
lymphocyte-to-monocyte ratio (LMR)
monocyte-to-lymphocyte ratio (MLR)
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Xinwen Zhang
Xinwen Zhang
Jialin Duan
Jialin Duan
Zhenyu Wen
Hao Xiong
Hao Xiong
Xiaomin Chen
Xiaomin Chen
Yang Liu
Yang Liu
Kunyu Liao
Kunyu Liao
Chunlan Huang
Chunlan Huang
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
description BackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.MethodsRelevant literatures were retrieved from PubMed, Embase and Web of Science databases according to PRISMA guideline. All relevant parameters were extracted and combined for statistical analysis.ResultsNineteen studies incorporating 3818 MM patients were eventually included in this meta-analysis. 13 studies evaluated that elevated NLR was significantly associated with poor survival outcomes (OS: HR=2.04, P<0.001; PFS: HR=1.96, P=0.003). Elevated NLR was revealed to correlate with ISS stage (ISS III VS I-II, OR=2.23, P=0.003). A total of 7 studies have shown that elevated LMR predicts a better prognosis in MM patients (OS: HR=0.57, P<0.001; PFS: HR=0.49, P<0.05), and two other studies demonstrated that increased MLR was related to poor OS/PFS (OS: HR=1.58, P<0.05; PFS: HR=1.60, P<0.05). However, in the other 6 studies including 1560 patients, the prognostic value of PLR had not been confirmed (OS: HR=0.89, P>0.05; PFS: HR=0.87, P>0.05).ConclusionsThe indexes NLR and LMR/MLR derived from WBCC were validated to be useful biomarkers to predict the prognosis in MM patients, but the evidence of PLR was insufficient.
format article
author Xinwen Zhang
Xinwen Zhang
Jialin Duan
Jialin Duan
Zhenyu Wen
Hao Xiong
Hao Xiong
Xiaomin Chen
Xiaomin Chen
Yang Liu
Yang Liu
Kunyu Liao
Kunyu Liao
Chunlan Huang
Chunlan Huang
author_facet Xinwen Zhang
Xinwen Zhang
Jialin Duan
Jialin Duan
Zhenyu Wen
Hao Xiong
Hao Xiong
Xiaomin Chen
Xiaomin Chen
Yang Liu
Yang Liu
Kunyu Liao
Kunyu Liao
Chunlan Huang
Chunlan Huang
author_sort Xinwen Zhang
title Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_short Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_full Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_fullStr Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_full_unstemmed Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_sort are the derived indexes of peripheral whole blood cell counts (nlr, plr, lmr/mlr) clinically significant prognostic biomarkers in multiple myeloma? a systematic review and meta-analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/eec690c52bbb4f60b59c45289f1ae5ee
work_keys_str_mv AT xinwenzhang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT xinwenzhang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT jialinduan arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT jialinduan arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT zhenyuwen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT haoxiong arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT haoxiong arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT xiaominchen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT xiaominchen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT yangliu arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT yangliu arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT kunyuliao arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT kunyuliao arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT chunlanhuang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT chunlanhuang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
_version_ 1718406599032176640